Monday 17 May 2021
Home      All news      Contact us      RSS      India
oneindia.com - 27 days ago

J J seeks permission for phase-3 trial of its single-shot COVID vaccine in India, import licence

New Delhi, Apr 19: Multinational pharma giant Johnson Johnson has applied to India s drug regulator seeking permission to conduct phase-3 clinical trial of its single-dose COVID-19 vaccine in India as well as import licence, sources said. They said the company has


Latest News
Hashtags:   

seeks

 | 

permission

 | 

phase

 | 

trial

 | 

single

 | 

COVID

 | 

vaccine

 | 

India

 | 

import

 | 

licence

 | 

Sources